Citius Oncology, Inc. (CTOR) Operating income 2022–2025
Citius Oncology, Inc. (CTOR) annual operating income history from SEC filings — each fiscal year as reported.
-$23.5MFY2025 · since FY2022: -$138,115 → -$23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.5M | -14.3% |
| FY2024 | -$20.6M | -1930.7% |
| FY2023 | -$1.0M | -633.5% |
| FY2022 | -$138,115 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTOR financial trends
CTOR RevenueCTOR Net incomeCTOR Net marginCTOR Gross profitCTOR Gross marginCTOR Operating marginCTOR Operating cash flowCTOR Free cash flowCTOR Capital expendituresCTOR Return on equityCTOR Stock buybacksCTOR Dividends paidCTOR Total assetsCTOR Total liabilitiesCTOR Shareholders’ equityCTOR overview →